1-3 of 3
Eric Schadt, PhD
Close
Sort by
Journal Articles

Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma

Deepak Perumal, PhD, Alessandro Lagana', PhD, Alex Rubinsteyn, PhD, John P Finnigan, Jr., BS, Pei-Yu Kuo, MS, Violetta V Leshchenko, PhD, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Jeff Hammerbacher, BA, Eric Schadt, PhD, Nina Bhardwaj, MD PhD, Samir Parekh, MD
Journal: Blood
Blood (2015) 126 (23): 1851.
https://doi.org/10.1182/blood.V126.23.1851.1851
Published: 2015
Journal Articles

Single Molecule Real Time (SMRT™) Sequencing Sensitively Detects Polyclonal and Compound BCR-ABL in Patients Who Relapse on Kinase Inhibitor Therapy,

Catherine C. Smith, MD, Michael Brown, PhD, Jason Chin, PhD, Corynn Kasap, BS, Sara Salerno, BS, Lauren E. Damon, Kevin Travers, PhD, Susana Wang, Andrew Kasarskis, PhD, Eric Schadt, PhD, Neil Shah, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3752.
https://doi.org/10.1182/blood.V118.21.3752.3752
Published: 2011
Journal Articles

Validation of FLT3-ITD As a Therapeutic Target in Human Acute Myeloid Leukemia

Catherine C. Smith, MD, Jason Chin, PhD, Qi Wang, PhD, Sara Salerno, BS, Lauren E. Damon, Jeremy P. Hunt, Mark J. Levis, MD, PhD, Alexander E Perl, MD, Kevin Travers, PhD, Susana Wang, Andrew Kasarskis, PhD, Eric Schadt, PhD, John Kuriyan, PhD, Neil Shah, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 937.
https://doi.org/10.1182/blood.V118.21.937.937
Published: 2011